Investing.com - Bicycle Therapeutics (NASDAQ:BCYC) reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Bicycle Therapeutics announced earnings per share of $-0.83 on revenue of $3.85M. Analysts polled by Investing.com anticipated EPS of $-0.4725 on revenue of $4.6M.
Bicycle Therapeutics shares are up 50.42% from the beginning of the year, still down 18.18% from its 52 week high of $33.00 set on January 20. They are outperforming the Nasdaq which is up 3.96% from the start of the year.
Bicycle Therapeutics follows other major Healthcare sector earnings this month
Bicycle Therapeutics's report follows an earnings beat by Medtronic on February 23, who reported EPS of $1.29 on revenue of $7.78B, compared to forecasts EPS of $1.15 on revenue of $7.77B.
AstraZeneca ADR had missed expectations on February 11 with fourth quarter EPS of $0.535 on revenue of $7.41B, compared to forecast for EPS of $0.5504 on revenue of $7.12B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar